Recent news on Eraxis

Pfizer is up off the mat -- now is the time to move  -  Mar 22, 2007
Blogging StocksRecently approved compounds on the Pfizer marketing list include: Exubera, targeted towards diabetes; Eraxis for fungal infections; Chantix, indicated for

Pfizer's a Sell: Shrinking Top Line, No Blockbusters In the Pipeline  -  Mar 22, 2007
Seeking Alpha,These products are antibacterial agent Zeven (dalbavancin) and antifungal agent Eraxis (anidulafungin). The FDA approved Eraxis in March 2006 and Zeven in

Looking at medications from 2006  -  Jan 2, 2007
Times Daily (subscription),Eraxis (Rx, injection). Used for various types of Candida (fungus) infections. Such infections could be life--threatening; they're not the vaginal or

Pfizer Moat Check Is Positive  -  26 Dec 2006
Seeking Alpha,Eraxis - An antifungal approved to treat candidemia, the most deadly of the common hospital-acquired bloodstream infections, and other forms of Candida

Pfizer raises 2006 estimate, adds drug candidates  -  26 Dec 2006
Chicago Tribune,Pfizer acquired Zeven along with a product already on the market for treating hospital-acquired blood infections called Eraxis when it bought Vicuron

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional